Cogent Biosciences, Inc.
COGT • NASDAQ • Stock Fundamentals
Cogent Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrew R. Robbins, with a market cap of $5.6B.
Market Cap$5.6B
Employees164.0
CEOAndrew R. Robbins
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Cogent Biosciences, Inc. FAQ
Common questions about Cogent Biosciences, Inc.
Cogent Biosciences, Inc. (COGT) has a market capitalization of $5.6B and trades on NASDAQ.
Cogent Biosciences, Inc. has approximately 164 employees.